Ben Stone
Corporate Officer/Principal bei ANAPTYSBIO, INC.
Profil
Ben Stone is the founder of IconOVir Bio, Inc.,76Bio, Inc. He is currently working as the Chief Business Officer at AnaptysBio, Inc. Mr. Stone completed his undergraduate degree at the University of Pennsylvania and The Wharton School of the University of Pennsylvania.
Aktive Positionen von Ben Stone
Unternehmen | Position | Beginn |
---|---|---|
ANAPTYSBIO, INC. | Corporate Officer/Principal | 01.01.2022 |
Ehemalige bekannte Positionen von Ben Stone
Unternehmen | Position | Ende |
---|---|---|
IconOVir Bio, Inc.
IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Gründer | - |
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Gründer | - |
Ausbildung von Ben Stone
University of Pennsylvania | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
76bio, Inc.
76bio, Inc. Pharmaceuticals: MajorHealth Technology 76Bio, Inc. is a private company that aims to develop transformational therapies for patients with life-threatening diseases. The company is based in New York, NY. The company focuses on pioneering the next generation of degradation by design. 76Bio was founded by Joshua A. Kazam, David M. Tanen, Marius Pop, Christopher Wilfong, Ben Stone, Angela Koehler, Arie S. Belldegrun, and K. Dane Wittrup. Christopher Wilfong has been the CEO since incorporation. | Health Technology |
IconOVir Bio, Inc.
IconOVir Bio, Inc. BiotechnologyHealth Technology IconOVir Bio, Inc. is an American biotechnology company that operates in the field of life sciences. The company was founded in 2018 by Arie S. Belldegrun, Ben Stone. The CEO is Mark A. McCamish. | Health Technology |